InsidersTradesSigma
Track the Xvivo Perfusion Aktiebolag stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Xvivo Perfusion Aktiebolag has recorded 3 reports. Market capitalisation: €8.9bn. The latest transaction was filed on 13 August 2025 (Purchase). Among the most active insiders: Gösta Johannesson. The full history is accessible without an account.
Analysts rate Xvivo Perfusion Aktiebolag Strong Buy (bullish), based on 5 analysts. Average price target: SEK 337.00.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations